Ra Capital Management, L.p. bought $75M of SEPN
director, owner at Septerna, Inc.. 4,170,000 shares at an average of $18.00, traded Oct 28, 2024, filed Oct 30, 2024.
Score components
- +15RoleDirector
- +25Trade size$75.1M at market
- +10Relative to holdingsHoldings up 246%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +24.2%, 3m -23.7%, 6m -65.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-025781, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 28, 2024 | CConversion Common Stockindirect: See footnotes | +1,695,515 | - | - | 1,695,515 | Oct 30, 2024 |
| Oct 28, 2024 | CConversion Common Stockindirect: See footnotes | +1,130,343 | - | - | 1,130,343 | Oct 30, 2024 |
| Oct 28, 2024 | POpen-market purchase Common Stockindirect: See footnotes | +3,828,400 | $18.00 | $69M | 5,523,915 | Oct 30, 2024 |
| Oct 28, 2024 | POpen-market purchase Common Stockindirect: See footnotes | +341,600 | $18.00 | $6.1M | 1,471,943 | Oct 30, 2024 |
| Oct 28, 2024 | CConversion Series B Preferred Stockderivativeindirect: See Footnotes | -14,598,896 | - | - | 0 | Oct 30, 2024 |
| Oct 28, 2024 | CConversion Series B Preferred Stockderivativeindirect: See Footnotes | -9,732,596 | - | - | 0 | Oct 30, 2024 |
Related signals
Other insiders at Septerna, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Septerna, Inc. | Daniel D. Long SVP, Drug Discovery | $126k 3,333 shares | -3% | |
| 40Moderate | Septerna, Inc. | Alan Ezekowitz director | $92k 13,319 shares | +13% | |
| 51Moderate | Septerna, Inc. | Alan Ezekowitz director | $516k 86,681 shares | +498% | |
| 43Moderate | Septerna, Inc. | Jeffrey Finer CEO and President | $97k 17,000 shares | +2% | |
| 43Moderate | Septerna, Inc. | Third Rock Ventures V, L.P. owner | $12M 650,000 shares | +11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.